(1 - 16 von 32
)
FDA gives nod to new antidepressant - UPI.comwww.upi.com › Science_News › › FDA...
www.upi.com
· Ivan Gergel, vice president of clinical development at Forest, told United Press International. "But we recognized the potential here and ...
Endo übernimmt die Lizenz für eine neue Schmerzbehandlung...
www.ots.at
Österreichs größtes Portal für multimediale Presseinformationen
Stockwatch
www.stockwatch.com
No Hype - just the Facts. Your complete source of news and realtime quotes from the TSX, TSX-V, CSE, Montreal, Nasdaq, NYSE, Amex and OTC Markets.
Corium Announces Appointment of Ivan Gergel, M.D. to Board of...
www.globenewswire.com
appointment comes at a most opportune time given the progress we ...
Nektar Appoints Ivan Gergel, M.D. as Senior Vice President, Drug...
ir.nektar.com
/* Style Definitions */
span.prnews_span
{
font-size:8pt;
font-family:
Endo to Acquire Penwest in Deal with Enterprise Value of $144M | GEN...
www.genengnews.com
Both firms’ boards approved the merger, but shareholder investigations have begun.
New Rhein Healthcare Investors moving headquarters to Philadelphia -...
pennbizreport.com
The opening of the Philadelphia office coincides with two new additions to the company's investment team. Dr. Ivan Gergel joins the company ...
BioDelivery, Endo commence Phase 3 programme for BEMA Buprenorphine -...
www.clinicaltrialsarena.com
· Ivan Gergel said, "With a long-standing history and success in developing innovative solutions for pain management, BEMA Buprenorphine ...
Butterfly Medical raises $7 million Series B financing led by New...
www.mobihealthnews.com
Investment proceeds will primarily fund FDA registration studies and opening of US headquarters.
Retrophin Names President and Chief Operations Officer - PharmaVOICE...
www.pharmavoice.com
Retrophin has appointed Stephen Aselage as president and chief operations officer.
Suit vs. Forest Labs Names Execs Linked to Alleged Lies About...
www.cbsnews.com
Employees of Forest Labs and that company's rivals should read the U.S. government's complaint against the company, which alleges off-label promotion...
FDA refuses approval for Endo's Aveed again - PharmaTimeswww.pharmatimes.com › news › fda_refuses_appro...
www.pharmatimes.com
· ... for AVEED," said Ivan Gergel, executive vice president of research and development and chief scientific of Endo Health Solutions.
Orion and Endo Establish Cancer Drug Alliance - Genetic ...www.genengnews.com › translational-medicine › or...
www.genengnews.com
· “This alliance marks another milestone in the transformation of Endo's R&D platform,” adds Ivan Gergel, M.D., executive vp for R&D at Endo.
sortiert nach Relevanz / Datum